RPID rapidmicrobio.com Projected Price to Earnings

Corporate company logo of Rapid Micro Biosystems (RPID)

The price action of Rapid Micro Biosystems (RPID) on the GURU.Markets platform demonstrates the 0.00 indicator. The financial stability of Rapid Micro Biosystems is strengthening through a combination of equipment sales and recurring revenue from ancillary materials. The company is actively scaling by automating sterility testing within the pharmaceutical industry. The implementation of the Growth Direct system accelerates time-to-market for drugs, providing a technological advantage in the field of biomaterial control.

RPID - Rapid Micro Biosystems Market Cap to Projected Earnings over the range 07/04/2022 - 11/12/2026

Financial and market metric breakdowns for Rapid Micro (RPID)

- stock value and consensus price forecast:
Price Chart Rapid Micro Biosystems|RPID - Analyst Median Target
- market capitalization data:
Market Valuation Rapid Micro Biosystems Inc.|RPID - Aggregate Business Value
- issuer book value statistics:
Book Value per Share Rapid Micro Biosystems|RPID - Book Valuation of Business|Market Capitalization to Book Value Ratio rapidmicrobio.com|RPID - Cumulative Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Rapid Micro Biosystems|RPID - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Rapid Micro Biosystems|RPID - Company Total Debt|Debts to Book Capitalization Rapid Micro Biosystems Inc.|RPID - Long-Term Debt|Company Short-Term Debts Rapid Micro Biosystems|Quick Ratio rapidmicrobio.com
- earnings and market ratios statistics:
RPID - Net Financial Result|Projected Future Earnings Rapid Micro Biosystems|RPID - Price to Earnings Ratio|Forward P/E Multiple Rapid Micro Biosystems|RPID - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rapid Micro Biosystems Inc.|RPID - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Rapid Micro Biosystems|RPID - Earnings per share for the trailing year|Quarterly EPS earnings growth rapidmicrobio.com|RPID - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Rapid Micro Biosystems
Fundamental company analysis:Rapid Micro Biosystems, Inc.
Product sample of Rapid Micro Biosystems

Assessing the asset quality of Rapid Micro Biosystems (RPID) requires an analysis of market expectations regarding future earnings. This forward P/E ratio compares the current share price with the expected earnings per share. The metric reflects the market's willingness to pay for technological superiority in rapid bacterial detection. This indicator's trend allows for the prompt identification of overvalued innovations without waiting for quarterly reports, thereby minimizing the risks of inefficient capital lock-up.

Competitors of Rapid Micro Biosystems (RPID)

Future Price to Earnings Abbott (ABT)|Market Cap to Projected Earnings Thermo Fisher Scientific Inc.|GE Healthcare Corp - Projected Price to Earnings|Market Cap to Future Earnings Ratio MTD (Mettler Toledo Inc)|Waters Corporation - Forward P/E Multiple|Market Cap to Projected Earnings bio-techne.com TECH|BRKR: Forward P/E Multiple|Projected Price to Earnings Azenta Inc|Projected Price to Earnings VREX|SMLR: Future Price to Earnings Multiple|Future Price to Earnings Butterfly Network, Inc. (BFLY)|Projected Price to Earnings mesalabs.com MLAB|Forward P/E Multiple QSI (Quantum-Si Incorporated)|Nano-X Imaging (NNOX) - Projected Price to Earnings Ratio|Quanterix Corp - Forward P/E Multiple|MASS (908 Devices Corporation) - Price to Future Earnings Ratio|CV: Forward P/E Multiple|MXCT - Market Cap to Projected Earnings|SEER (Seer) - Forward P/E Multiple|Projected Price to Earnings Hyperfine Inc (HYPR)|Forward P/E Multiple FONR|Forward P/E Multiple daxor.com (DXR)|Future Price to Earnings Spectral AI MDAI|organovo.com - Future Price to Earnings|ACON: Projected Price to Earnings|Future Price to Earnings Multiple AKYA (Akoya Biosciences)|THMO: Forward P/E Multiple|Projected Price to Earnings Ratio Talis Biomedical Corporation (TLIS)|Future Price to Earnings T2 Biosystems, Inc.